MiP Pharma Group is an internationally operating, medium-sized pharmaceutical company with its headquarters, development and production in Germany and with a corporate history going back more than 65 years. Together with our 270-strong team, we are a reliable and sustainable pharmaceutical supplier in Germany and Europe.
As laid out in our mission statement, we are fully focused on reliably supplying our customers with high-quality medicines.
We have been manufacturing drugs in our modern, GMP-certified production facilities located in the Saarland, both for our own sales and under contract manufacturing (CMO) for other pharmaceutical companies since 1970.
Our sales focus is on the hospital sector and on catering for select medical specialists such as dentists and urologists. Our main markets are in Germany, Poland and other eastern European countries; MiP Pharma currently operates 17 locations outside of Germany.
Qualified staff, state-of-the-art production facilities and efficient processes as well as an appreciative and performance-enhancing corporate culture are the basis of our ongoing success.
Thanks to our recognized excellent reliability as a supplier and outstanding customer orientation, we were named “Best Pharmaceutical supplier” for the hospital sector in Germany on a number of occasions.
In late 2020, MiP Pharma Group was acquired by Berlin-based capiton AG with the participation of the management.
The company has since been pursuing a consistent growth strategy with focus on specialized markets and portfolios, continuous modernization and expansion of production facilities, as well as cost optimization of all processes. In fiscal year 2021/22, MiP Group's sales grew by approx. 15% to a record turnover of around EUR 50 million.
You can find the latest information about us here.